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Background: Advance care planning (ACP) is increasingly recognised as important in chronic
obstructive pulmonary disease (COPD). Specialist respiratory physicians (RPs) are crucial in
enabling ACP in patients with COPD. Accordingly, understanding their practice and attitudes
regarding ACP is important.
Methods: We developed and piloted a survey to assess RPs practices, attitudes and educational
needs in ACP.
Results: The response rate was 41% (17/41). The instrument was brief and acceptable to par-
ticipants. Among respondents, 13% reported they had discussed ACP with “most” of their pa-
tients; 31% with “about half”; 50% with “a few” and 6% with “none or almost none”. Althoughof Respiratory Medicine, Campbelltown Hospital, PO Box 149, Campbelltown, NSW 2560, Australia.
(mobile); fax: þ61 2 4634 4011.
s.health.nsw.gov.au (T.A. Smith).
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936 T.A. Smith et al.57% of respondents preferred outpatient discussions, most discussions occurred as inpatients.
Diagnosis, purpose of treatment and incurability of COPD were reported as commonly dis-
cussed but the appointment of a health care proxy, the patients’ values and goals, and palli-
ative care options were rarely addressed. Reported barriers to ACP included: difficulty
prognosticating; time constraints; and perceived patient reticence. Facilitators included
increasing patient frailty and patient willingness to discuss. Most respondents reported
receiving some formal training in ACP and refined skills by observing colleagues. Many were
interested in further educational opportunities.
Conclusion: This pilot found the new instrument was acceptable. Findings suggest that ACP
discussions are infrequent with the majority occurring in the inpatient setting, with key ele-
ments omitted. Participants generally had favourable attitudes to ACP and recognised for
the need for ongoing training. These early findings require further investigation.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a respi-
ratory illness, characterised by unpredictable exacerba-
tions [1]. Exacerbations may result in respiratory failure,
necessitating rapid decision-making, and advance care
planning (ACP) has been advocated [1e3]. ACP is a patient-
centred process which involves elucidating patients’ values
and preferences regarding treatments, including life sus-
taining therapies [2e4]. Respiratory physicians (RPs) are
key providers in COPD, however their views regarding ACP
have received little attention [5,6].
We describe developing and piloting a survey to under-
stand RPs views of ACP in COPD patients. In addition, we
report the ACP practices, attitudes and educational expe-
riences and needs of respondents.Methods
After a thorough literature review revealed no appropriate
tool, we developed a survey by selecting items from 3
relevant, validated tools [7e9] plus developed questions
from relevant literature [5,6,10]. We specified respondents
should describe their views regarding ACP with patients
with GOLD class III and IV COPD.
The survey comprised six sections:
1. Sociodemographic characteristics
2. Practice of ACP in last month
3. Attitudes to ACP: Likert scale.
4. Content of ACP conversations: including how frequently
16 topics were discussed and prompts for discussion.
5. Barriers and facilitators of ACP
6. Educational experience and needs
After ethics approval, RPs from four urban Australian
hospitals were invited to participate. Survey data were
analysed using SPSS V19 and are reported using descriptive
statistics. Where rates are reported, the denominator is the
number of respondents answering the question. Depending
on the construct assessed, several items were reverse
coded to calculate Cronbach’s alpha. A Cronbach alpha of
greater than 0.7 was regarded as suggesting acceptableinternal consistency. Further methodological detail is
available in the Supplementary material.
Results
Sociodemographic Characteristics
Forty-one per cent (17/41) of invitees completed this pilot
survey. Participants were experienced RPs (median number
GOLD class III/IV COPD patients per month 20, interquartile
range (IQR) 7e26; median years post-graduate experience
of 10e15years, IQR 5e10 to 20e25years.)
The median time for survey completion was 11e20 min.
Three respondents omitted only one or two questions. One
respondent could not answer one section due to not un-
dertaking clinical work in the last month. Qualitative
feedback suggested the survey was clear, concise and
acceptable.
Practice of ACP in last month
Two respondents (13% of 16 answering) reported discussing
ACP with “most” GOLD class III/IV patients seen in the last
month. Five (31%) respondents reported discussing ACP
with “about half”, 8 (50%) with “a few” and 1 (6%) with
“none or almost none patients”. Although 47% (8/17) of
respondents preferred discussing ACP in the outpatient
setting, 80% (12/15) reported discussions occurred “mostly”
or “always” in hospital.
Attitudes to ACP
Median responses suggest positive attitudes to ACP (Table
1). The majority agreed that ACP: was important for pa-
tients with life-threatening disease; may improve satisfac-
tion with end of life care; and may reduce the likelihood of
futile treatment. Twelve (71%) found ACP challenging due
to difficulty prognosticating. Six (35%) agreed ACP could
destroy a patients’ sense of hope. Three (18%) agreed ACP
conflicted with other chronic disease management goals.
Four (24%) disagreed with the statement “ACP is a specialist
physicians responsibility”. The Cronbach alpha of 0.89
suggests good internal consistency.
Table 1 Attitudes of participants to advance care planning.
Strongly
agree 1a
Agree 2a Undecided 3a Disagree 4a Strongly
disagree 5a
Median
Physician views about advance care planning purpose and impact
ACP is important to patients who are diagnosed with
life-threatening diseases
11 (64.7%) 6 (35.3%) 0 0 0 1
Most patients with advanced COPD want to know
about their diagnosis, prognosis, and available care
options.
1 (6.3%) 10 (62.5%) 2 (12.5%) 3 (18.8%) 0 2
ACP reduces the likelihood of futile treatment at the
end of life.
7 (41.2%) 7 (41.2%) 3 (17.6%) 0 0 2
ACP can improve patients’ and families’ satisfaction
about end-of-life care.
6 (35.3%) 10 (58.8%) 1 (5.9%) 0 0 2
The practice of ACP is consistent with patient-
centred care standards
5 (29.4%) 11 (64.7%) 1 (5.9%) 0 0 2
Most patients with advanced COPD, if asked, want to
discuss their wishes for end-of-life care
1 (5.9%) 6 (35.3%) 6 (35.3%) 3 (17.6%) 1 (5.9%) 3
ACP can destroy patients’ sense of hope 0 6 (35.3%) 3 (17.6%) 7 (41.2%) 1 (5.9%) 3
Physician comfort and confidence with advance care planning
I feel confident in my ability to communicate “bad
news.”
3 (17.6%) 12 (70.6%) 1 (5.9%) 1 (5.9%) 0 2
I have sufficient knowledge about how to conduct
ACP conversations with patients and their families.
2 (11.8%) 10 (58.8%) 4 (23.5%) 1 (5.9%) 0 2
I feel comfortable discussing ACP with patients with
advanced COPD.
5 (31.3%) 8 (50%) 1 (6.3%) 2 (12.5%) 0 2
I feel comfortable discussing issues related to death
and dying with patients with advanced COPD and
their families.
5 (29.4%) 8 (47.1%) 2 (11.8%) 2 (11.8%) 0 2
My colleagues support me in discussing ACP with
patients and families.
5 (29.4%) 9 (52.9%) 2 (11.8%) 1 (5.9%) 0 2
ACP is a specialist physician’s responsibility 5 (29.4%) 7 (41.2%) 1 (5.9%) 4 (23.5%) 0 2
I am uncomfortable discussing do not resuscitate
orders with my patients
0 0 1 (5.9%) 14 (82.4%) 2 (11.8%) 4
I am reluctant to discuss ACP unless the conversation
is initiated by the patient
0 1 (5.9%) 2 (11.8%) 14 (82.4%) 0 4
Timing of advance care planning
I think it is essential to discuss ACP after recovery in
patients with hypercapnic respiratory failure
requiring NIV.
7 (41.2%) 6 (35.3%) 1 (5.9%) 3 (17.6%) 0 2
Deciding when to initiate ACP in patients with
advanced COPD is difficult as accurate
prognostication is very difficult.
2 (11.8%) 10 (58.8%) 1 (5.9%) 4 (23.5%) 0 2
I do not have time to address all of my patients
concerns at a single office/outpatient visit
2 (11.8%) 9 (52.9%) 0 6 (35.3%) 0 2
Beliefs about appropriateness of advance care planning
ACP should be discussed at a routine outpatient visit
when the patient is healthy
3 (17.6%) 7 (41.2%) 5 (29.4%) 1 (5.9%) 1 (5.9%) 2
All adult patients with COPD, regardless of age,
should be offered the opportunity to discuss ACP
3 (17.6%) 10 (58.8%) 2 (11.8%) 2 (11.8%) 0 2
In the absence of a serious of life threatening illness,
there is no reason for a patient to establish an
advance care plan
2 (11.8%) 2 (11.8%) 3 (17.6%) 10 (58.8%) 0 4
It is NOT appropriate to discuss ACP with seriously ill
patients who may recover to their premorbid level
of functioning
0 1 (5.9%) 4 (23.5%) 11 (64.7%) 1 (5.9%) 4
Perceived adverse consequences of advance care planning discussion
I am concerned that having ACP discussions with my
COPD patients, will make them feel that I have
“given up” on them
0 0 7 (41.2%) 9 (52.9%) 1 (5.9%) 4
(continued on next page)
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Strongly
agree 1a
Agree 2a Undecided 3a Disagree 4a Strongly
disagree 5a
Median
In the past, when I have had ACP conversations with
my patients I felt it led to them losing confidence in
my care
0 1 (5.9%) 6 (35.3%) 9 (52.9%) 1 (5.9%) 4
I am concerned that having ACP discussions with my
COPD patients will lead to them not returning to me
for further follow up.
0 2 (12.5%) 2 (12.5%) 10 (62.5%) 2 (12.5%) 4
Discussing ACP conflicts with my responsibility to
advocate for ICU level care/intubation for my COPD
patients
0 3 (17.6%) 2 (11.8%) 9 (52.9%) 3 (17.6%) 4
I feel the idea of ACP conflicts with other chronic
disease management goals in COPD (such as
encouraging exercise, smoking cessation etc)
1 (5.9%) 2 (11.8%) 1 (5.9%) 10 (58.8%) 3 (17.6%) 4
ACP Z Advance Care Planning. COPD Z Chronic Obstructive Pulmonary Disease. This table relates to results from Section 3 of the
survey.
a Scores assigned to responses to allow calculation of medians.
938 T.A. Smith et al.Content of ACP discussions
Regarding content of ACP discussions (Table S2 Supple-
mentary material) most (>50%) respondents discussed the
following “most” or “all or almost all” of the time: diag-
nosis; incurability of disease; purpose of medical treat-
ment; and symptom management options and reported it
was their “routine” to do so. Few (<30%) discussed
appointment of health-care proxy, palliative care options
and the patients’ goals, values and beliefs “most “or “all or
almost all” of the time.
Barriers and facilitators of ACP
Most (15/17 (88%)), reported “sometimes” or “often”
feeling that patients and their families don’t want to
discuss ACP, usually (15/17,88%) detecting this via “subtle
cues”. Reported barriers to ACP included prognostication,
cultural issues and time constraints. Enabling factors
included increasing frailty, patients accepting their illness
and education for patient/family.
Educational experience and needs
Many RPs (11/17, (65%)), reported previous ACP education;
81% (13/16) reported learning ACP skills informally by
adopting ACP skills from others and 81% (13/16) reported an
interest in further ACP education.
Discussion
Respondents demonstrated positive attitudes to ACP,
however a minority reported ACP was not their role, and/or
conflicted chronic disease management. Elements of ACP
were frequently omitted. That RPs almost uniformly detect
patient and family reluctance to discuss ACP by “subtle
cues” is novel, raising questions for future research.
ACP discussions appear infrequent (44% discussed ACP
with the majority of patients), however, this rate is higher
than reported in other clinician populations [11,12]. While47% of respondents preferred discussing ACP outside hos-
pital, discussions most often occurred in hospital, similar to
a survey of North American Internists [9]. Research suggests
COPD patients would prefer not to discuss ACP in this
setting [13].
Respondents valued ACP, similar to other studies [8,12].
Conflict between ACP and other chronic disease manage-
ment goals was reported, similar to a British qualitative
study [5]. While respondents worried about destroying
hope, a study in renal patients suggests ACP can enhance
hope [14]. Concerningly, some respondents felt ACP was
not a specialist physician’s role, congruent with other work
[15]. Topics frequently discussed included incurability of
disease and purpose of medical treatment, similar to other
research [7]. However, foundation elements of ACP
including the appointment of a proxy and the patients’
values were less commonly discussed.
That RPs report adopting ACP skills from others is un-
surprising, however raises the questions of what is being
taught, what is learnt, and how the learner practises new
skills. The interest in further education suggests educa-
tional interventions may facilitate practice improvement.
The small sample, responder bias, and small number of
sites are clear limitations, particularly limiting general-
isability. A key strength of this study is it establishes a brief,
acceptable instrument that requires further psychometric
evaluation. The preliminary insights provided by this study
deserve further evaluation. Future studies should explore
the relationship between prognostication and ACP, and
time taken for ACP. Specific conflicts with other care goals,
and means of remediating these deserve exploration.
Furthermore, understanding the “subtle cues” RPs detect
that suggest to them that patients and families do not wish
to discuss ACP deserve further attention.
Conclusion
This pilot establishes a promising, acceptable instrument to
assess attitudes to and practices of ACP. While RPs saw
value in ACP, findings suggest it was infrequently under-
taken with key elements omitted. Pleasingly, there was
Respiratory physicians’ views of ACP in COPD 939enthusiasm for further education. As specialist providers
are crucial in initiating and enabling ACP, further under-
standing in this area is essential.
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